Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays skeletal muscle degradation in mice

Nutrients

Volumn 8, Issue 9, 2016, Pages

  Soni, Nikul K ^a   Ross, Alastair B ^a   Scheers, Nathalie ^a   Savolainen, Otto I ^a   Nookaew, Intawat ^a,b   Gabrielsson, Britt G ^a   Sandberg, Ann Sofie ^a  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Eicosapentaenoic acid (EPA) Docosahexaenoic acid (DHA); Mitochondrial oxidation; Obesity; Skeletal muscle metabolism; Transcriptome

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ALPHA ACTIN; ALPHA TROPOMYOSIN; CALCINEURIN; CALCIUM CHANNEL L TYPE; CORN OIL; DOCOSAHEXAENOIC ACID; FATTY ACID ESTER; GLYCOGEN SYNTHASE KINASE 3BETA; ICOSAPENTAENOIC ACID; MYOGENIN; MYOSIN HEAVY CHAIN; NICOTINIC RECEPTOR; NUCLEAR FACTOR OF ACTIVATED T CELLS 4 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOLIPID; SOMATOMEDIN; TRANSCRIPTION FACTOR GATA 5; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTOME; TROPONIN C; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; FATTY ACID ANALYSIS; FATTY ACID OXIDATION; GENE EXPRESSION; INFLAMMATION; LIPID COMPOSITION; LIPID DIET; MALE; MASS FRAGMENTOGRAPHY; METABOLIC DISORDER; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; MOUSE; MUSCLE CONTRACTION; MUSCLE MASS; MUSCLE METABOLISM; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; RNA ISOLATION; SKELETAL MUSCLE; TRANSCRIPTOMICS; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUSCLE MITOCHONDRION; PATHOLOGY; PROCEDURES; SKELETAL MUSCLE CELL; TIME FACTOR;

ANIMALS; CORN OIL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; MICE, INBRED C57BL; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OBESITY; OXIDATIVE PHOSPHORYLATION; TIME FACTORS; TRANSCRIPTOME;

EID: 84987703623     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8090543     Document Type: Article

References (58)

1. World Health Organization. Obesity and Overweight Fact Sheet N_311; World Health Organization Media Centre: Geneva, Switzerland, 2015.
2. Lauretani, F.; Russo, C.R.; Bandinelli, S.; Bartali, B.; Cavazzini, C.; Di Iorio, A.; Corsi, A.M.; Rantanen, T.; Guralnik, J.M.; Ferrucci, L. Age-associated changes in skeletal muscles and their effect on mobility: An operational diagnosis of sarcopenia. J. Appl. Physiol. 2003, 95, 1851–1860. [CrossRef] [PubMed]
3. Candow, D.G.; Chilibeck, P.D. Differences in size, strength, and power of upper and lower body muscle groups in young and older men. J. Gerontol. 2005, 60, 148–156. [CrossRef]
4. Von Haehling, S.; Morley, J.E.; Anker, S.D. An overview of sarcopenia: Facts and numbers on prevalence and clinical impact. J. Cachexia Sarcopenia Muscle 2010, 1, 129–133. [CrossRef] [PubMed]
5. Rosenberg, I.H. Sarcopenia: Origins and clinical relevance. J. Nutr. 1997, 127, 990S–991S. [CrossRef] [PubMed]
6. Schmidt, M.; Johannesdottir, S.A.; Lemeshow, S.; Lash, T.L.; Ulrichsen, S.P.; Botker, H.E.; Sorensen, H.T. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: A danish 33-year follow-up study. BMJ Open 2013, 3. [CrossRef] [PubMed]
7. Roubenoff, R. Sarcopenic obesity: The confluence of two epidemics. Obes. Res. 2004, 12, 887–888. [CrossRef] [PubMed]
8. Schaap, L.A.; Pluijm, S.M.; Deeg, D.J.; Harris, T.B.; Kritchevsky, S.B.; Newman, A.B.; Colbert, L.H.; Pahor, M.; Rubin, S.M.; Tylavsky, F.A. et al. Higher inflammatory marker levels in older persons: Associations with 5-year change in muscle mass and muscle strength. J. Gerontol. 2009, 64, 1183–1189. [CrossRef] [PubMed]
9. Visser, M.; Pahor, M.; Taaffe, D.R.; Goodpaster, B.H.; Simonsick, E.M.; Newman, A.B.; Nevitt, M.; Harris, T.B. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The health abc study. J. Gerontol. 2002, 57, M326–M332. [CrossRef]
10. Zhao, X.; Wang, Z.; Zhang, J.; Hua, J.; He, W.; Zhu, S. Estimation of total body skeletal muscle mass in chinese adults: Prediction model by dual-energy X-ray absorptiometry. PLoS ONE 2013, 8. [CrossRef] [PubMed]
11. Kim, J.; Wang, Z.; Heymsfield, S.B.; Baumgartner, R.N.; Gallagher, D. Total-body skeletal muscle mass: Estimation by a new dual-energy X-ray absorptiometry method. Am. J. Clin. Nutr. 2002, 76, 378–383.
12. Meyer, C.; Dostou, J.M.; Welle, S.L.; Gerich, J.E. Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 2002, 282, 419–427. [CrossRef] [PubMed]
13. Smith, G.I.; Julliand, S.; Reeds, D.N.; Sinacore, D.R.; Klein, S.; Mittendorfer, B. Fish oil-derived n-3 pufa therapy increases muscle mass and function in healthy older adults. Am. J. Clin. Nutr. 2015, 102, 115–122. [CrossRef] [PubMed]
14. Alexander, J.W.; Saito, H.; Trocki, O.; Ogle, C.K. The importance of lipid type in the diet after burn injury. Ann. Surg. 1986, 204, 1–8. [CrossRef] [PubMed]
15. Gingras, A.A.; White, P.J.; Chouinard, P.Y.; Julien, P.; Davis, T.A.; Dombrowski, L.; Couture, Y.; Dubreuil, P.; Myre, A.; Bergeron, K. et al. Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the akt-mtor-s6k1 pathway and insulin sensitivity. J. Physiol. 2007, 579, 269–284. [CrossRef] [PubMed]
16. Fetterman, J.W., Jr.; Zdanowicz, M.M. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am. J Health Syst. Pharm. 2009, 66, 1169–1179. [CrossRef] [PubMed]
17. Gabrielsson, B.G.; Wikstrom, J.; Jakubowicz, R.; Marmon, S.K.; Carlsson, N.G.; Jansson, N.; Gan, L.M.; Undeland, I.; Lonn, M.; Holmang, A. et al. Dietary herring improves plasma lipid profiles and reduces atherosclerosis in obese low-density lipoprotein receptor-deficient mice. Int. J. Mol. Med. 2012, 29, 331–337. [CrossRef] [PubMed]
18. Nookaew, I.; Gabrielsson, B.G.; Holmang, A.; Sandberg, A.S.; Nielsen, J. Identifying molecular effects of diet through systems biology: Influence of herring diet on sterol metabolism and protein turnover in mice. PLoS ONE 2010, 5. [CrossRef] [PubMed]
19. Rodacki, C.L.; Rodacki, A.L.; Pereira, G.; Naliwaiko, K.; Coelho, I.; Pequito, D.; Fernandes, L.C. Fish-oil supplementation enhances the effects of strength training in elderly women. Am. J. Clin. Nutr. 2012, 95, 428–436. [CrossRef] [PubMed]
20. Smith, G.I.; Atherton, P.; Reeds, D.N.; Mohammed, B.S.; Rankin, D.; Rennie, M.J.; Mittendorfer, B. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: A randomized controlled trial. Am. J. Clin. Nutr. 2011, 93, 402–412. [CrossRef] [PubMed]
21. Soni, N.K.; Nookaew, I.; Sandberg, A.S.; Gabrielsson, B.G. Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice. Lipids Health Dis. 2015, 14. [CrossRef] [PubMed]
22. Amrutkar, M.; Cansby, E.; Nunez-Duran, E.; Piraz zi, C.; Stahlman, M.; Stenfeldt, E.; Smith, U.; Boren, J.; Mahlapuu, M. Protein kinase stk25 regulates hepatic lipid partitioning and progression of liver steatosis and nash. FASEB J. 2015, 29, 1564–1576. [CrossRef] [PubMed]
23. For More Information about ncbi refseq, Please Go to http://ftp.Ncbi.Nih.Gov/refseq/release/.
24. For More Information about meebo, Please Go to http://www.Arrays.Ucsf.Edu/archive/meebo.Html.
25. Functional Annotation of Mouse. Available online: http://fantom2.Gsc.Riken.Jp/ (accessed on 25 August 2016).
26. Du, P.; Kibbe, W.A.; Lin, S.M. Lumi: A pipeline for processing illumina microarray. Bioinformatics 2008, 24, 1547–1548. [CrossRef] [PubMed]
27. Ritchie, M.E.; Phipson, B.; Wu, D.; Hu, Y.; Law, C.W.; Shi, W.; Smyth, G.K. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl. Acids Res. 2015, 43. [CrossRef]
28. Luo, W.; Friedman, M.S.; Shedden, K.; Hankenson, K.D.; Woolf, P.J. Gage: Generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 2009, 10, 1–17. [CrossRef] [PubMed]
29. Luo, W.; Brouwer, C. Pathview: An R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 2013, 29. [CrossRef] [PubMed]
30. Folch, J.; Lees, M.; Stanley, G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [PubMed]
31. Kaluzny, M.A.; Duncan, L.A.; Merritt, M.V.; Epps, D.E. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J. Lipid Res. 1985, 26, 135–140. [PubMed]
32. Lepage, G.; Roy, C.C. Improved recovery of fatty acid through direct transesterification without prior extraction or purification. J. Lipid. Res. 1984, 25, 1391–1396. [PubMed]
33. Tuazon, M.A.; Henderson, G.C. Fatty acid profile of skeletal muscle phospholipid is altered in mdx mice and is predictive of disease markers. Metable 2012, 61, 801–811. [CrossRef] [PubMed]
34. Lowell, B.B.; Shulman, G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307, 384–387. [CrossRef] [PubMed]
35. Petersen, K.F.; Dufour, S.; Befroy, D.; Garcia, R.; Shulman, G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004, 350, 664–671. [CrossRef] [PubMed]
36. Patti, M.E.; Butte, A.J.; Crunkhorn, S.; Cusi, K.; Berria, R.; Kashyap, S.; Miyazaki, Y.; Kohane, I.; Costello, M.; Saccone, R. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of pgc1 and nrf 1. Proc. Natl. Acad. Sci. USA 2003, 100, 8466–8471. [CrossRef] [PubMed]
37. Sparks, L.M.; Xie, H.; Koza, R.A.; Mynatt, R.; Hulver, M.W.; Bray, G.A.; Smith, S.R. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005, 54, 1926–1933. [CrossRef] [PubMed]
38. Mootha, V.K.; Lindgren, C.M.; Eriksson, K.F.; Subramanian, A.; Sihag, S.; Lehar, J.; Puigserver, P.; Carlsson, E.; Ridderstrale, M.; Laurila, E. et al. Pgc-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34, 267–273. [CrossRef] [PubMed]
39. Choi, C.S.; Savage, D.B.; Abu-Elheiga, L.; Liu, Z.X.; Kim, S.; Kulkarni, A.; Distefano, A.; Hwang, Y.J.; Reznick, R.M.; Codella, R. et al. Continuous fat oxidation in acetyl-coa carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc. Natl. Acad. Sci. USA 2007, 104, 16480–16485. [CrossRef] [PubMed]
40. Bruce, C.R.; Hoy, A.J.; Turner, N.; Watt, M.J.; Allen, T.L.; Carpenter, K.; Cooney, G.J.; Febbraio, M.A.; Kraegen, E.W. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 2009, 58, 550–558. [CrossRef] [PubMed]
41. Schwerzmann, K.; Hoppeler, H.; Kayar, S.R.; Weibel, E.R. Oxidative capacity of muscle and mitochondria: Correlation of physiological, biochemical, and morphometric characteristics. Proc. Natl. Acad. Sci. USA 1989, 86, 1583–1587. [CrossRef] [PubMed]
42. Petersen, K.F.; Befroy, D.; Dufour, S.; Dziura, J.; Ariyan, C.; Rothman, D.L.; DiPietro, L.; Cline, G.W.; Shulman, G.I. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 2003, 300, 1140–1142. [CrossRef] [PubMed]
43. Periasamy, M.; Kalyanasundaram, A. Serca pump isoforms: Their role in calcium transport and disease. Muscle Nerve 2007, 35, 430–442. [CrossRef] [PubMed]
44. Radzyukevich, T.L.; Neumann, J.C.; Rindler, T.N.; Oshiro, N.; Goldhamer, D.J.; Lingrel, J.B.; Heiny, J.A. Tissue-specific role of the na,k-atpase alpha2 isozyme in skeletal muscle. J. Biol. Chem. 2013, 288, 1226–1237. [CrossRef] [PubMed]
45. Dunn, S.E.; Burns, J.L.; Michel, R.N. Calcineurin is required for skeletal muscle hypertrophy. J. Biol. Chem. 1999, 274, 21908–21912. [CrossRef] [PubMed]
46. Dunn, S.E.; Chin, E.R.; Michel, R.N. Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fiber growth. J. Cell. Biol. 2000, 151, 663–672. [CrossRef] [PubMed]
47. Dunn, S.E.; Simard, A.R.; Bassel-Duby, R.; Williams, R.S.; Michel, R.N. Nerve activity-dependent modulation of calcineurin signaling in adult fast and slow skeletal muscle fibers. J. Biol. Chem. 2001, 276, 45243–45254. [CrossRef] [PubMed]
48. Hughes, S.M.; Taylor, J.M.; Tapscott, S.J.; Gurley, C.M.; Carter, W.J.; Peterson, C.A. Selective accumulation of myod and myogenin mrnas in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development 1993, 118, 1137–1147.
49. Lin, J.; Wu, H.; Tarr, P.T.; Zhang, C.Y.; Wu, Z.; Boss, O.; Michael, L.F.; Puigserver, P.; Isotani, E.; Olson, E.N. et al. Transcriptional co-activator pgc-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418, 797–801. [CrossRef] [PubMed]
50. Vega, R.B.; Huss, J.M.; Kelly, D.P. The coactivator pgc-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell Biol. 2000, 20, 1868–1876. [CrossRef] [PubMed]
51. Wu, Z.; Puigserver, P.; Andersson, U.; Zhang, C.; Adelmant, G.; Mootha, V.; Troy, A.; Cinti, S.; Lowell, B.; Scarpulla, R.C. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98, 115–124. [CrossRef]
52. Puigserver, P.; Wu, Z.; Park, C.W.; Graves, R.; Wright, M.; Spiegelman, B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92, 829–839. [CrossRef]
53. Noland, R.C.; Woodlief, T.L.; Whitfield, B.R.; Manning, S.M.; Evans, J.R.; Dudek, R.W.; Lust, R.M.; Cortright, R.N. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E986–E1001. [CrossRef] [PubMed]
54. Neal, J.W.; Clipstone, N.A. Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J. Biol. Chem. 2001, 276, 3666–3673. [CrossRef] [PubMed]
55. Baker, W.L.; Karan, S.; Kenny, A.M. Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: A systematic review. J. Am. Geriatr. Soc. 2011, 59, 997–1002. [CrossRef] [PubMed]
56. Emmelot-Vonk, M.H.; Verhaar, H.J.; Pour, H.R.N.; Aleman, A.; Lock, T.M.; Bosch, J.L.; Grobbee, D.E.; van der Schouw, Y.T. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: A randomized controlled trial. J. Am. Med. Assoc. 2008, 299, 39–52. [CrossRef] [PubMed]
57. Giannoulis, M.G.; Sonksen, P.H.; Umpleby, M.; Breen, L.; Pentecost, C.; Whyte, M.; McMillan, C.V.; Bradley, C.; Martin, F.C. The effects of growth hormone and/or testosterone in healthy elderly men: A randomized controlled trial. J. Clin. Endocrinol. Metab. 2006, 91, 477–484. [CrossRef] [PubMed]
58. Kirwan, J.P.; Solomon, T.P.; Wojta, D.M.; Staten, M.A.; Holloszy, J.O. Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 2009, 297, E151–E156. [CrossRef] [PubMed]